Maxion Therapeutics


Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

Employees

11-50

Links


Org chart

Collapse
John Mccafferty
Co-founder And CTO
Aneesh Karatt Vellatt
Chief Scientific Officer, Board Director
Sylwia Mankowska
Director Of Operations
Stefan Härtle
Chief Development Officer (cdo)
Joel Edwards
Chief Business Officer

Teams

This company has no teams yet